Tremelimumab (anti-CTLA-4)
Tremelimumab (Ticilimumab, CP-675,206) is a fully human monoclonal antibody that binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on the surface of activated T lymphocytes.
| Trivial name | Ticilimumab, CP-675,206 |
| Catalog Number | A2021 |
| CAS# | 745013-59-6 |
| Size | 1mg*25 |
| Supplier Page | http://www.selleckchem.com/products/tremelimumab-anti-ctla-4.html |